The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function
Paule V. Joseph, Ph.D., MBA, MS, FNP-BC, CTN-B, FAAN
Lasker Clinical Research Scholar
NIH Distinguished Scholar
Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD
Co-Director, National Smell and Taste Center
Attending Nurse Practitioner
Division of Intramural Clinical and Biological Research
National Institute on Alcohol Abuse and Alcoholism
National Institute on Deafness and Other Communication Disorders
Pioneers in Biomedical Research Seminar
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function
Date: Dec. 11, 2026
Time: 11 a.m. to noon
In-person: Room G101 A/B, 4 Riverside Circle
Virtual: Join via Zoom
About this Seminar
Chemosensory dysfunction -— impairments in smell and taste -— is an often-overlooked yet deeply consequential dimension of health. In this talk, Dr. Joseph explores how these sensory deficits intersect with alcohol use, mental health, and quality of life. Drawing from multiple studies, she will highlight emerging evidence that links heavy alcohol consumption to altered chemosensory perception, including diminished sensitivity to harmful stimuli and increased sensitivity to rewarding ones. The discussion will also examine how sensory distortions such as parosmia and phantosmia relate to problematic drinking and depressive symptoms. These findings reveal that chemosensory dysfunction is not a peripheral issue. It can shape behavior, emotional well-being, and even social engagement. Dr. Joseph will argue for the integration of sensory health assessments into the clinical and public health frameworks for alcohol use disorders, suggesting that early detection of smell and taste changes could serve as a critical window for intervention.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Why Measure? , homeSept. 17, 2026, 5:30 p.m. (Reception at 5 p.m.) | Christopher S. Hourigan, DM, DPhil, FRCP, Professor and Director, Cancer Research Center — D.C., Fralin Biomedical Research Institute | Maury Strauss Distinguished Public Lecture
-
Home Item
Brown Adipose Tissue as a Mediator of Cardiovascular Health , homeSept. 18, 2026, 11:00 a.m. | Kristin Stanford, Ph.D., FAHA, Professor, Department of Surgery; William D. and Jacquelyn L. Wells Chair, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Exercise Medicine Research
-
Home Item
mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back , homeSept. 25, 2026, 11:00 a.m. | Elena Goncharova, Ph.D., ATSF, FAHA, Professor, Department of Internal Medicine; Director, Pulmonary Vascular Disease Program, UC Davis School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
How Can Research Inform Better Public Policy Towards Addiction? , homeOct. 2, 2026, 11:00 a.m. | Keith Humphreys, OBE, Ph.D., Esther Ting Memorial Professor, Department of Psychiatry, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research
-
Home Item
Exercise, the Fountain of Youth? , homeOct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture
-
Home Item
Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , homeOct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.